The estimated Net Worth of James A Hayward is at least $4.29 Million dollars as of 20 November 2014. James Hayward owns over 76,923 units of Applied Dna Sciences Inc stock worth over $2,898,074 and over the last 18 years he sold APDN stock worth over $0. In addition, he makes $1,392,560 as Chairman of the Board, President, and Chief Executive Officer at Applied Dna Sciences Inc.
James has made over 3 trades of the Applied Dna Sciences Inc stock since 2006, according to the Form 4 filled with the SEC. Most recently he bought 76,923 units of APDN stock worth $249,231 on 20 November 2014.
The largest trade he's ever made was buying 259,000 units of Applied Dna Sciences Inc stock on 1 September 2006 worth over $36,260. On average, James trades about 31,685 units every 170 days since 2006. As of 20 November 2014 he still owns at least 1,919,254 units of Applied Dna Sciences Inc stock.
You can see the complete history of James Hayward stock trades at the bottom of the page.
Dr. James A. Hayward, Ph.D., is Chairman of the Board, President, Chief Executive Officer of the company. He was previously our acting Chief Executive Officer since October 5, 2005. He also served as Acting Chief Financial Officer from August 20, 2013 through October 13, 2013. Dr. Hayward received his Ph.D. in Molecular Biology from the State University of New York at Stony Brook in 1983 and an honorary Doctor of Science from the same institution in 2000. His experience with public companies began with the co-founding of one of England’s first biotechnology companies–Biocompatibles. Following this, Dr. Hayward was Head of Product Development for the Estee Lauder companies for five years. In 1990 he founded The Collaborative Group, a provider of products and services to the biotechnology, pharmaceutical and consumer-product industries based in Stony Brook, where he served as Chairman, President and Chief Executive Officer for 14 years. During this period, The Collaborative Group created several businesses, including The Collaborative BioAlliance, a contract developer and manufacturer of human gene products, that was sold to Dow Chemical in 2002, and Collaborative Labs, a service provider and manufacturer of ingredients for skincare and dermatology that was sold to Engelhard (now BASF) in 2004.
As the Chairman of the Board, President, and Chief Executive Officer of Applied Dna Sciences Inc, the total compensation of James Hayward at Applied Dna Sciences Inc is $1,392,560. There are no executives at Applied Dna Sciences Inc getting paid more.
James Hayward is 62, he's been the Chairman of the Board, President, and Chief Executive Officer of Applied Dna Sciences Inc since 2013. There are 5 older and 9 younger executives at Applied Dna Sciences Inc. The oldest executive at Applied Dna Sciences Inc is Robert Catell, 80, who is the Director.
James's mailing address filed with the SEC is 50, Health Sciences Drive, Stony Brook University, Suffolk, New York, 11794, United States.
Over the last 21 years, insiders at Applied Dna Sciences Inc have traded over $13,655,198 worth of Applied Dna Sciences Inc stock and bought 12,115,698 units worth $17,246,871 . The most active insiders traders include Management Inc Rhl, Lawrence Lee, and Dwyer Management Inc O. On average, Applied Dna Sciences Inc executives and independent directors trade stock every 59 days with the average trade being worth of $312,035. The most recent stock trade was executed by Scott L Anchin on 10 March 2021, trading 13,049 units of APDN stock currently worth $110,003.
we keep life real and safe by providing botanical-dna based security and authentication solutions and services that protect assets, products, brands, supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion.
Applied Dna Sciences Inc executives and other stock owners filed with the SEC include: